This publication is a biased interpretation of some potentially serious safety issues. The data should be audited and reanalyzed by an independent cardiologist. Legangneux E, Gardin A, Johns D. Br J Clin Pharmacol. 2013 Mar;75(3):831-41. Dose titration of BAF312 attenuates the initial heart rate reducing effect in healthy subjects.
